Advertisement
Articles
Subscribe to Drug Discovery & Development Articles

The Lead

Promising Malaria and Dengue Vaccines Will Not Defeat Diseases

May 20, 2015 | by Christopher J. Pace, Ph.D., GlobalData Managing Analyst, Infectious Diseases | Comments

Some industry pundits rightfully question the modest protective efficacies of CYD-TDV and RTS,S/AS01. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Injected T Cells from Bone Marrow Treat Multiple Myeloma, Pilot Study Finds

May 21, 2015 1:12 pm | by Stephanie Guzowski, Editor | Comments

In a first small clinical trial of its kind, researchers harnessed T cells from patients’ own bone marrow to treat multiple myeloma and provide immune protection for up to a year, according to a study published this week in Science Translational Medicine. Read more...

TOPICS:

Activists Want to Void Patents on Gilead's High-Priced Hepatitis C Drug

May 20, 2015 12:15 pm | by Ryan Bushey, Associate Editor | Comments

These patents are being challenged all over the world. Read more...

TOPICS:

Abcodia Raises $8M to Launch Ovarian Cancer Screening Test

May 19, 2015 1:14 pm | by Ryan Bushey, Associate Editor | Comments

The test will officially be on the market in the U.S. and U.K. later this year. Read more...

TOPICS:
Advertisement

Global Dyslipidemia Treatment Market Value Will Approach $38B by 2023

May 19, 2015 8:44 am | by Valentina Gburcik, Ph.D., Director of Cardiovascular & Metabolic Disorders, GlobalData | Comments

The global treatment market for dyslipidemia will more than double in value from $15.4 billion in 2013 to an estimated $37.9 billion by 2023. Read more...

TOPICS:

Cancer Institute of NJ Investigates Promising Immunotherapy for Toughest Lung Cancers

May 14, 2015 11:47 am | by Seth Augenstein, Digital Reporter | Comments

Small-cell lung cancer, often caused by smoking, is among the most stubborn diseases in oncology. While it might respond initially to chemotherapy, it often recurs – and comes back even more resistant to treatment. But a new use of a known immunotherapy, bolstering the body’s immune system, is showing some promise against this disease, according to research taking place at the Rutgers Cancer Institute of New Jersey. Read more...

TOPICS:

B Vitamin May Prevent Recurrence of Skin Cancers

May 14, 2015 11:33 am | by Ryan Bushey, Associate Editor | Comments

A study conducted by scientists at Australia’s University of Sydney found that a form of vitamin B3 has the potential to lower the chance of developing skin cancer. Read more...

TOPICS:

AstraZeneca to Focus on Precision Medicine for Asthma, Heart Disease

May 13, 2015 9:50 am | by Ryan Bushey, Associate Editor | Comments

Abbot Laboratories and the Montreal Heart Institute will help the company with this project. Read more..

TOPICS:

The U.S. Looks to Improve on Cuba's Lung Cancer Vaccine

May 12, 2015 8:38 am | by Ryan Bushey, Associate Editor | Comments

The injection is being evaluated as a possible preventative intervention. Read more...

TOPICS:
Advertisement

Tribeca Disruptive Innovation Awards: From Detecting HIV to Nanoscale Imaging

May 11, 2015 3:24 pm | by Cynthia Fox, Science Editor | Comments

In the spirit of its title, this year’s Tribeca Film Festival’s Disruptive Technologies awards ceremony did not distinguish between work that was only simple or complex; only big or small. It focused on work that angled to disrupt the norm, or “transcend limits,” said presenter and Tribeca Film Institute co-founder Craig Hatkoff. Read more...

TOPICS:

GSK, UNC Team Up to Fight HIV

May 11, 2015 10:47 am | by Ryan Bushey, Associate Editor | Comments

Glaxo will spend a total of $20 million over the next five years to fund this endeavor.  Read more...

TOPICS:

Nanotechnology Applications in Drug Delivery

May 8, 2015 4:28 pm | by Michael Morgen, Ph.D., Bend Research Inc., a division of Capsugel Dosage Form Solutions | Comments

In recent years nanotechnology has received significant interest for a wide range of applications, including those within the pharmaceutical industry.  In this area in particular, a number of diverse nano-sized structures have been investigated for drug formulation and delivery. Read more...

TOPICS:

Large Numbers of Trial Results Go Unreported; WHO Says “Report Them”

May 8, 2015 8:39 am | by Cynthia Fox, Science Editor | Comments

The World Health Organization (WHO) announced what many feel is a strong, long-overdue statement condemning parties who do not report results of clinical trials in a timely way. By one account, more than 30 percent of industry and academic groups in the U.S. have not reported results of their clinical trials for 60 months, plus. The WHO outlined specific, and strict, solutions. Read more...

TOPICS:

Tackling the Challenges of Antibody Development

May 7, 2015 9:30 am | by Tim Moran, director of life science research at BIOVIA | Comments

As organizations in the pharmaceutical and biopharmaceutical space shift their focus from small molecules to protein-based therapies, they can no longer rely on traditional research approaches. Read more...

TOPICS:

Kymab Raises $90M to Support Monoclonal Antibody Pipeline

May 7, 2015 8:26 am | by Ryan Bushey, Associate Editor | Comments

The Bill and Melinda Gates Foundation was one of the primary investors this round. Read more...

TOPICS:

Stem Cells Safe to Treat Post-Stroke Brains, Study Says

May 6, 2015 11:17 am | by Seth Augenstein, Digital Reporter | Comments

​Stem cells can be safely infused to the brain through the carotid artery after a stroke, according to new research presented by a group of doctors and researchers. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading